Korean Coronary Bifurcation Stenting (COBIS) Registry III

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2648 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-02-28

Study Completion Date

2018-12-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The COBIS III registry is a multi-center, real-world registry of 2nd generation drug-eluting stenting in coronary bifurcation lesions in South Korea. From 21 major coronary intervention centers in Korea, a total of 3,000 patients (anticipated) will be enrolled in this database between January 2010 and December 2014.

The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with 2nd generation drug-eluting stents for coronary bifurcation lesions in South Korea.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Smart Angioplasty Research Team-Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion With Drug-Coated Balloon

NCT07019350

Coronary Artery Disease

RECRUITING NA

Korean Multicenter Registry of EPIC Stent for Iliac Artery Disease: (K-EPIC Registry)

NCT02698358

Iliac Artery Disease

UNKNOWN

To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent

NCT03089450

Ischemic Heart Disease Stable Coronary Artery Disease Stable Angina +2 more

UNKNOWN NA

DXR Stent(Previous Cilotax) Implantation Registry

NCT01612819

Coronary Artery Diseases

TERMINATED

In-Stent Restenosis Post-Approval Study

NCT02542267

Peripheral Artery Disease Vascular Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Bifurcation Lesion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Coronary Bifurcation Lesion

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>=19 years
* Any type of de novo bifurcation lesion in major epicardial artery: unprotected left main coronary bifurcation lesion, LAD - diagonal, LCX-OM, distal RCA bifurcation. (Excluding RCA-RV branch bifurcation, branch bifurcation)
* Side branch or LCX reference diameter \>= 2.3 mm and at least stentable with 2.5 mm stent
* Treated with drug-eluting stent during the period of 2010. 1 \~ 2014. 12

Exclusion Criteria

* Protected left main disease previous CABG for LAD or LCX territory
* Cardiogenic Shock
* History of CPR in the same hospitalization
* Patients with severe left ventricular systolic dysfunction (ejection fraction \< 30%)

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No